Content
April 2017, Volume 18, Issue 3
- 373-386 The role of time and risk preferences in adherence to physician advice on health behavior change
by Marjon Pol & Deirdre Hennessy & Braden Manns - 387-398 Analyzing disparity trends for health care insurance coverage among non-elderly adults in the US: evidence from the Behavioral Risk Factor Surveillance System, 1993–2009
by Shireen Assaf & Stefano Campostrini & Cinzia Di Novi & Fang Xu & Carol Gotway Crawford
March 2017, Volume 18, Issue 2
- 135-138 Competition in the healthcare sector: a missing dimension
by Peter Zweifel - 139-153 Competition in the Dutch hospital sector: an analysis of health care volume and cost
by Y. J. F. M. Krabbe-Alkemade & T. L. C. M. Groot & M. Lindeboom - 155-165 Preferences for antiviral therapy of chronic hepatitis C: a discrete choice experiment
by Axel C. Mühlbacher & John F. P. Bridges & Susanne Bethge & Ch.-Markos Dintsios & Anja Schwalm & Andreas Gerber-Grote & Matthias Nübling - 167-180 How can the regulator show evidence of (no) risk selection in health insurance markets? Conceptual framework and empirical evidence
by Wynand P. M. M. Ven & René C. J. A. Vliet & Richard C. Kleef - 181-193 Four years of early benefit assessment of new drugs in Germany: a qualitative study on methodological requirements for quality of life data
by Christine Blome & Matthias Augustin & Hidayet Metin & David Lohrberg - 195-208 Financial incentives, timing of births, and infant health: a closer look into the delivery room
by Hendrik Jürges - 209-226 A voluntary deductible in health insurance: the more years you opt for it, the lower your premium?
by K. P. M. Winssen & R. C. Kleef & W. P. M. M. Ven - 227-241 Assessing asthma severity based on claims data: a systematic review
by Christian Jacob & Jennifer S. Haas & Benno Bechtel & Peter Kardos & Sebastian Braun - 243-253 The cost of frailty in France
by Nicolas Sirven & Thomas Rapp - 255-267 Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort
by Han-I. Wang & Alexandra Smith & Eline Aas & Eve Roman & Simon Crouch & Cathy Burton & Russell Patmore
January 2017, Volume 18, Issue 1
- 1-5 Priorities in the Polish health care system
by Sylwia Nieszporska - 7-12 A short note on measuring subjective life expectancy: survival probabilities versus point estimates
by David R. Rappange & Job van Exel & Werner B. F. Brouwer - 13-31 The impact of a sick pay waiting period on sick leave patterns
by Catherine Pollak - 33-47 An empirical comparison of Markov cohort modeling and discrete event simulation in a capacity-constrained health care setting
by L. B. Standfield & T. A. Comans & P. A. Scuffham - 49-58 Economic burden of toxicities associated with treating metastatic melanoma in eight countries
by Elizabeth Wehler & Zhongyun Zhao & S. Pinar Bilir & Julie Munakata & Beth Barber - 59-71 Why trash don’t pass? pharmaceutical licensing and safety performance of drugs
by Tannista Banerjee & Arnab Nayak - 73-82 Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study
by Tomáš Mlčoch & Jiří Klimeš & Libor Fila & Věra Vávrová & Veronika Skalická & Marek Turnovec & Veronika Krulišová & Jitka Jirčíková & Dana Zemková & Klára Vilimovská Dědečková & Alena Bílková & Vladimíra Frühaufová & Lukáš Homola & Zuzana Friedmannová & Radovan Drnek & Pavel Dřevínek & Tomáš Doležal & Milan Macek - 83-96 Crisis, suicide and labour productivity losses in Spain
by Berta Rivera & Bruno Casal & Luis Currais - 97-117 Competition and quality in a physiotherapy market with fixed prices
by Piia Pekola & Ismo Linnosmaa & Hennamari Mikkola - 119-129 Medical ethics: enhanced or undermined by modes of payment?
by Peter Zweifel & Katharina Janus - 131-132 Commentary to: Medical ethics: enhanced or undermined by modes of payment?
by Friedrich Breyer - 133-134 Reply to commentary on: medical ethics: enhanced or undermined by modes of payment?
by Peter Zweifel & Katharina Janus
December 2016, Volume 17, Issue 9
- 1055-1058 Incentivizing research into the effectiveness of medical devices
by Michael Drummond & Rosanna Tarricone & Aleksandra Torbica - 1059-1072 Potential determinants of deductible uptake in health insurance: How to increase uptake in The Netherlands?
by K. P. M. Winssen & R. C. Kleef & W. P. M. M. Ven - 1073-1089 Does smoke cross the border? Cigarette tax avoidance in France
by Christian Ben Lakhdar & Nicolas Gérard Vaillant & François-Charles Wolff - 1091-1100 Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland
by Mark Fisher & Andrew Walker & Meritxell Falqués & Miguel Moya & Mark Rance & Douglas Taylor & Leandro Lindner - 1101-1115 The hidden economic burden of air pollution-related morbidity: evidence from the Aphekom project
by Olivier Chanel & Laura Perez & Nino Künzli & Sylvia Medina - 1117-1124 Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden
by J. Banefelt & S. Hallberg & K. M. Fox & J. Mesterton & C. J. Paoli & G. Johansson & L.-Å. Levin & P. Sobocki & S. R. Gandra - 1125-1140 What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences
by Axel Mühlbacher & Susanne Bethge - 1141-1158 The costs and consequences of obesity in Germany: a new approach from a prevalence and life-cycle perspective
by Tobias Effertz & Susanne Engel & Frank Verheyen & Roland Linder - 1159-1172 A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failure
by F. Tomini & F. Prinzen & A. D. I. Asselt - 1173-1184 Exploring the determinants of endocrinologist visits by patients with diabetes
by Luiz Flavio Andrade & Thomas Rapp & Christine Sevilla-Dedieu
November 2016, Volume 17, Issue 8
- 923-926 Reimbursable drug classes and ceilings in Italy: why not only one?
by Livio Garattini & Alessandro Curto & Anna Padula - 927-938 Choice of statistical model for cost-effectiveness analysis and covariate adjustment: empirical application of prominent models and assessment of their results
by Theodoros Mantopoulos & Paul M. Mitchell & Nicky J. Welton & Richard McManus & Lazaros Andronis - 939-950 Multiple imputation strategies for zero-inflated cost data in economic evaluations: which method works best?
by Janet MacNeil Vroomen & Iris Eekhout & Marcel G. Dijkgraaf & Hein van Hout & Sophia E. de Rooij & Martijn W. Heymans & Judith E. Bosmans - 951-961 A cost analysis of orthopedic foot surgery: can outpatient continuous regional analgesia provide the same standard of care for postoperative pain control at home without shifting costs?
by Andrea Saporito & Stefano Calciolari & Laura Gonzalez Ortiz & Luciano Anselmi & Alain Borgeat & José Aguirre - 963-977 The simultaneous effects of pharmaceutical policies from payers’ and patients’ perspectives: Italy as a case study
by Patrizio Armeni & Claudio Jommi & Monica Otto - 979-990 The time horizon matters: results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitation
by Louis S. Matza & Kristina S. Boye & David H. Feeny & Lee Bowman & Joseph A. Johnston & Katie D. Stewart & Kelly McDaniel & Jessica Jordan - 991-999 Direct cost of pars plana vitrectomy for the treatment of macular hole, epiretinal membrane and vitreomacular traction: a bottom-up approach
by Elena Nicod & Timothy L. Jackson & Federico Grimaccia & Aris Angelis & Marc Costen & Richard Haynes & Edward Hughes & Edward Pringle & Hadi Zambarakji & Panos Kanavos - 1001-1010 Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain
by Manel Mata-Cases & Marc Casajuana & Josep Franch-Nadal & Aina Casellas & Conxa Castell & Irene Vinagre & Dídac Mauricio & Bonaventura Bolíbar - 1011-1026 Is higher nursing home quality more costly?
by L. Di Giorgio & M. Filippini & G. Masiero - 1027-1040 The diffusion of generics after patent expiry in Germany
by Katharina Elisabeth Fischer & Tom Stargardt - 1041-1053 Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature
by David Epstein & Leticia García-Mochón & Stephen Kaptoge & Simon G. Thompson
September 2016, Volume 17, Issue 7
- 787-789 Improving health care systems by building ‘more Europe’
by F. Antoñanzas & C. A. Juárez-Castelló & R. Rodríguez-Ibeas - 875-884 Multiple sclerosis: relapses, resource use, and costs
by A. J. Hawton & C. Green - 897-910 Marginal revenue and length of stay in inpatient psychiatry
by Mark Pletscher - 911-921 OnabotulinumtoxinA in the treatment of overactive bladder: a cost-effectiveness analysis versus best supportive care in England and Wales
by Nick Freemantle & Kristin Khalaf & Clara Loveman & Sanja Stanisic & Dmitry Gultyaev & Johanna Lister & Marcus Drake
July 2016, Volume 17, Issue 6
- 653-657 The demand for health insurance and behavioural economics
by K. P. M. van Winssen & R. C. van Kleef & W. P. M. M. van de Ven - 659-668 Predicting hospital costs for patients receiving renal replacement therapy to inform an economic evaluation
by Bernadette Li & John Cairns & James Fotheringham & Rommel Ravanan - 669-679 Burden of influenza in Germany: a retrospective claims database analysis for the influenza season 2012/2013
by Jennifer Haas & Sebastian Braun & Peter Wutzler - 681-691 Forecasting the use of elderly care: a static micro-simulation model
by Evelien Eggink & Isolde Woittiez & Michiel Ras - 693-709 Health, work and working conditions: a review of the European economic literature
by Thomas Barnay - 711-721 Health resource utilization associated with skeletal-related events: results from a retrospective European study
by Jean-Jacques Body & João Pereira & Harm Sleeboom & Nikos Maniadakis & Evangelos Terpos & Yves Pascal Acklin & Jindrich Finek & Oliver Gunther & Guy Hechmati & Tony Mossman & Luis Costa & Wojciech Rogowski & Hareth Nahi & Roger Moos - 723-732 The true impact of the French pay-for-performance program on physicians’ benzodiazepines prescription behavior
by Audrey Michel-Lepage & Bruno Ventelou - 733-744 Estimating informal care inputs associated with EQ-5D for use in economic evaluation
by Donna Rowen & Simon Dixon & Mónica Hernández-Alava & Clara Mukuria - 745-754 Expected 10-year treatment cost of breast cancer detected within and outside a public screening program in Norway
by Tron A. Moger & Gudrun M. W. Bjørnelv & Eline Aas - 755-770 Economic evaluation in chronic pain: a systematic review and de novo flexible economic model
by W. Sullivan & M. Hirst & S. Beard & D. Gladwell & F. Fagnani & J. López Bastida & C. Phillips & W. C. N. Dunlop - 771-785 Pay or conditions? The role of workplace characteristics in nurses’ labor supply
by Barbara Eberth & Robert F. Elliott & Diane Skåtun
June 2016, Volume 17, Issue 5
- 519-520 ‘Catastrophic’ healthcare expenditure: critique of a problematic concept and a proposal
by Peter Zweifel
May 2016, Volume 17, Issue 4
- 375-377 Prioritizing health services research: an economic perspective
by Afschin Gandjour
April 2016, Volume 17, Issue 3
- 229-233 Competition among health care providers: helpful or harmful?
by Pedro Pita Barros & Werner B. F. Brouwer & Sarah Thomson & Marco Varkevisser - 371-373 Erratum to: Treatment costs of attention deficit hyperactivity disorder in Germany
by Sebastian Braun & Jan Zeidler & Roland Linder & Susanne Engel & Frank Verheyen & Wolfgang Greiner
March 2016, Volume 17, Issue 2
- 113-116 Access to primary care in Italy: time for a shake-up?
by Livio Garattini & Alessandro Curto & Nick Freemantle - 117-127 Are some QALYs more equal than others?
by E. Wetering & N. Exel & J. Rose & R. Hoefman & W. Brouwer - 129-137 Economic hardship and suicide mortality in Finland, 1875–2010
by Marko Korhonen & Mikko Puhakka & Matti Viren - 139-147 The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach
by A. Marcellusi & R. Viti & A. Mecozzi & F. Mennini - 149-158 Willingness to pay for health insurance among the elderly population in Germany
by Jens-Oliver Bock & Dirk Heider & Herbert Matschinger & Hermann Brenner & Kai-Uwe Saum & Walter Haefeli & Hans-Helmut König - 159-170 Informal payments in the Greek health sector amid the financial crisis: old habits die last..
by Kyriakos Souliotis & Christina Golna & Yannis Tountas & Olga Siskou & Daphne Kaitelidou & Lycourgos Liaropoulos - 171-183 Do insurers respond to risk adjustment? A long-term, nationwide analysis from Switzerland
by Viktor von Wyl & Konstantin Beck - 185-193 Understanding the economic impact of intravascular ultrasound (IVUS)
by Alessandro Alberti & Pietro Giudice & Alessandra Gelera & Luca Stefanini & Virginia Priest & Michael Simmonds & Christa Lee & Matthew Wasserman - 195-201 Healthcare costs and resource utilization of asthma in Germany: a claims data analysis
by Christian Jacob & Benno Bechtel & Susanne Engel & Peter Kardos & Roland Linder & Sebastian Braun & Wolfgang Greiner - 203-215 Lessons from state mandates of preventive cancer screenings
by Wendy Xu & Bryan Dowd & Jean Abraham - 217-227 Tramadol and the risk of fracture in an elderly female population: a cost utility assessment with comparison to transdermal buprenorphine
by Alexander Hirst & Chris Knight & Matt Hirst & Will Dunlop & Ron Akehurst
April 2016, Volume 17, Issue 1
- 1-5 Social/economic costs and health-related quality of life in patients with rare diseases in Europe
by Julio López-Bastida & Juan Oliva-Moreno & Renata Linertová & Pedro Serrano-Aguilar - 7-18 Social/economic costs and health-related quality of life in patients with cystic fibrosis in Europe
by Karine Chevreul & Morgane Michel & Karen Berg Brigham & Julio López-Bastida & Renata Linertová & Juan Oliva-Moreno & Pedro Serrano-Aguilar & Manuel Posada-de-la-Paz & Domenica Taruscio & Arrigo Schieppati & Georgi Iskrov & Márta Péntek & Johann Matthias Graf Schulenburg & Panos Kanavos & Ulf Persson & Giovani Fattore - 19-29 Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe
by Marianna Cavazza & Yllka Kodra & Patrizio Armeni & Marta Santis & Julio López-Bastida & Renata Linertová & Juan Oliva-Moreno & Pedro Serrano-Aguilar & Manuel Posada-de-la-Paz & Domenica Taruscio & Arrigo Schieppati & Georgi Iskrov & Márta Péntek & Johann Matthias Graf Schulenburg & Panos Kanavos & Karine Chevreul & Ulf Persson & Giovanni Fattore - 31-42 Social/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe
by Aris Angelis & Panos Kanavos & Julio López-Bastida & Renata Linertová & Juan Oliva-Moreno & Pedro Serrano-Aguilar & Manuel Posada-de-la-Paz & Domenica Taruscio & Arrigo Schieppati & Georgi Iskrov & Valentin Brodszky & Johann Matthias Graf Schulenburg & Karine Chevreul & Ulf Persson & Giovanni Fattore - 43-52 Social/economic costs and health-related quality of life in patients with fragile X syndrome in Europe
by Karine Chevreul & Coralie Gandré & Karen Berg Brigham & Julio López-Bastida & Renata Linertová & Juan Oliva-Moreno & Pedro Serrano-Aguilar & Manuel Posada-de-la-Paz & Domenica Taruscio & Arrigo Schieppati & Georgi Iskrov & László Gulácsi & Johann Matthias Graf Schulenburg & Panos Kanavos & Ulf Persson & Giovani Fattore - 53-65 Social/economic costs and quality of life in patients with haemophilia in Europe
by Marianna Cavazza & Yllka Kodra & Patrizio Armeni & Marta De Santis & Julio López-Bastida & Renata Linertová & Juan Oliva-Moreno & Pedro Serrano-Aguilar & Manuel Posada-de-la-Paz & Domenica Taruscio & Arrigo Schieppati & Georgi Iskrov & László Gulácsi & Johann Matthias Graf Schulenburg & Panos Kanavos & Karine Chevreul & Ulf Persson & Giovanni Fattore - 67-78 Social/economic costs and health-related quality of life in patients with histiocytosis in Europe
by Georgi Iskrov & Itziar Astigarraga & Rumen Stefanov & Julio López-Bastida & Renata Linertová & Juan Oliva-Moreno & Pedro Serrano-Aguilar & Manuel Posada-de-la-Paz & Arrigo Schieppati & Domenica Taruscio & Márta Péntek & Johann Matthias Graf Schulenburg & Panos Kanavos & Karine Chevreul & Ulf Persson & Giovanni Fattore - 79-87 Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe
by A. Kuhlmann & T. Schmidt & M. Treskova & J. López-Bastida & R. Linertová & J. Oliva-Moreno & P. Serrano-Aguilar & M. Posada-de-la-Paz & P. Kanavos & D. Taruscio & A. Schieppati & G. Iskrov & M. Péntek & C. Delgado & J. M. Schulenburg & U. Persson & K. Chevreul & G. Fattore - 89-98 Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe
by Márta Péntek & László Gulácsi & Valentin Brodszky & Petra Baji & Imre Boncz & Gábor Pogány & Julio López-Bastida & Renata Linertová & Juan Oliva-Moreno & Pedro Serrano-Aguilar & Manuel Posada-de-la-Paz & Domenica Taruscio & Georgi Iskrov & Arrigo Schieppati & Johann Matthias Graf Schulenburg & Panos Kanavos & Karine Chevreul & Ulf Persson & Giovanni Fattore - 99-108 Social/economic costs and health-related quality of life in patients with Prader-Willi syndrome in Europe
by Julio López-Bastida & Renata Linertová & Juan Oliva-Moreno & Manuel Posada-de-la-Paz & Pedro Serrano-Aguilar & Panos Kanavos & Domenica Taruscio & Arrigo Schieppati & Georgi Iskrov & Petra Baji & Claudia Delgado & Johann Matthias Graf Schulenburg & Ulf Persson & Karine Chevreul & Giovanni Fattore - 109-117 Social/economic costs and health-related quality of life in patients with scleroderma in Europe
by Julio López-Bastida & Renata Linertová & Juan Oliva-Moreno & Pedro Serrano-Aguilar & Manuel Posada-de-la-Paz & Panos Kanavos & Domenica Taruscio & Arrigo Schieppati & Georgi Iskrov & Márta Péntek & Claudia Delgado & Johann Mathias Schulenburg & Ulf Persson & Karine Chevreul & Giovanni Fattore
January 2016, Volume 17, Issue 1
- 1-4 Ebola fever epidemic 2014: a call for sustainable health and development policies
by Steffen Flessa & Michael Marx - 5-21 Differences in price elasticities of demand for health insurance: a systematic review
by Jonas Pendzialek & Dusan Simic & Stephanie Stock - 23-29 Is response to price equal for those with higher alcohol consumption?
by Joshua Byrnes & Anthony Shakeshaft & Dennis Petrie & Christopher Doran - 31-44 Estimating productivity costs using the friction cost approach in practice: a systematic review
by Jesse Kigozi & Sue Jowett & Martyn Lewis & Pelham Barton & Joanna Coast - 45-60 Entry time effects and follow-on drug competition
by Luiz Andrade & Catherine Sermet & Sylvain Pichetti - 61-69 Health care costs attributable to overweight calculated in a standardized way for three European countries
by M. Lette & W. Bemelmans & J. Breda & L. Slobbe & J. Dias & H. Boshuizen - 71-86 Wage subsidies and hiring chances for the disabled: some causal evidence
by Stijn Baert - 87-98 The economic impact of chronic pain: a nationwide population-based cost-of-illness study in Portugal
by Luís Azevedo & Altamiro Costa-Pereira & Liliane Mendonça & Cláudia Dias & José Castro-Lopes - 99-111 Is the United States in the middle of a healthcare bubble?
by Wen-Yi Chen & Yia-Wun Liang & Yu-Hui Lin
December 2015, Volume 16, Issue 9
- 913-915 Efficient health research and improving Europeans’ health
by Fernando Antoñanzas & Carmelo Juárez-Castelló & Roberto Rodríguez-Ibeas - 917-925 Values for health states with different life durations
by Luciana Scalone & Peep Stalmeier & Silvano Milani & Paul Krabbe - 927-939 EQ-5D in skin conditions: an assessment of validity and responsiveness
by Yaling Yang & John Brazier & Louise Longworth - 941-949 Endogenous risk-taking and physical appearance of sex workers
by Peter Egger & Andreas Lindenblatt - 951-956 An examination of the relationships between service use and alternative measures of obesity among community-dwelling adults in Ireland
by Edel Doherty & Michelle Queally & Ciaran O’Neill - 957-967 Health burden and costs of obesity and overweight in Germany: an update
by Thomas Lehnert & Pawel Streltchenia & Alexander Konnopka & Steffi Riedel-Heller & Hans-Helmut König - 969-983 Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals?
by David Granlund & Miyase Koksal-Ayhan - 985-994 Some economics on personalized and predictive medicine
by F. Antoñanzas & C. Juárez-Castelló & R. Rodríguez-Ibeas - 995-1004 Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer’s disease clinical trials
by Kristin Kahle-Wrobleski & Howard Fillit & Jonathan Kurlander & Catherine Reed & Mark Belger - 1005-1018 Health state utilities associated with attributes of treatments for hepatitis C
by Louis Matza & Sandhya Sapra & John Dillon & Anupama Kalsekar & Evan Davies & Mary Devine & Jessica Jordan & Amanda Landrian & David Feeny - 1019-1026 Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD)
by Fan Yang & Titus Lau & Evan Lee & A. Vathsala & Kee Chia & Nan Luo
November 2015, Volume 16, Issue 8
- 797-800 Rationing of health care: is there an economic rationality to it?
by Peter Zweifel - 801-811 Did the health of the Dutch population improve between 2001 and 2008? Investigating age- and gender-specific trends in quality of life
by Maria Gheorghe & Werner Brouwer & Pieter Baal - 813-834 Who is afraid of smoking bans? An evaluation of the effects of the Spanish clean air law on expenditure at hospitality venues
by Jaume García-Villar & Ángel López-Nicolás - 835-846 Who is responsible for your health: is it you, your doctor or the new technologies?
by Vincenzo Atella & Francesco D’Amico - 847-855 Between-country heterogeneity in EQ-5D-3L scoring algorithms: how much is due to differences in health state selection?
by Eleanor Pullenayegum & Kuhan Perampaladas & Kathryn Gaebel & Brett Doble & Feng Xie - 857-863 Do Chinese have similar health-state preferences? A comparison of mainland Chinese and Singaporean Chinese
by P. Wang & M. Li & G. Liu & J. Thumboo & N. Luo - 865-877 Differences in EQ-5D-3L health state valuations among patients with musculoskeletal diseases, health care professionals and healthy volunteers
by Anja Schwalm & You-Shan Feng & Jörn Moock & Thomas Kohlmann - 879-893 Economic evaluations of implantable cardioverter defibrillators: a systematic review
by Lidia García-Pérez & Pilar Pinilla-Domínguez & Antonio García-Quintana & Eduardo Caballero-Dorta & F. García-García & Renata Linertová & Iñaki Imaz-Iglesia - 895-905 Relationship between global severity of patients with Alzheimer’s disease and costs of care in Spain; results from the co-dependence study in Spain
by J. Darbà & L. Kaskens & L. Lacey - 907-907 Commentary to: Cost of poor adherence to anti-hypertensive therapy in five European countries
by Afschin Gandjour - 909-911 Reply to comment on Cost of poor adherence to anti-hypertensive therapy in five European country
by F. Mennini & Andrea Marcellusi & J. Schulenburg & A. Gray & P. Levy & P. Sciattella & M. Soro & G. Staffiero & J. Zeidler & A. Maggioni & R. Schmieder
September 2015, Volume 16, Issue 7
- 683-687 Western European markets for biosimilar and generic drugs: worth differentiating
by Livio Garattini & Alessandro Curto & Katelijne Vooren - 689-707 Costs of care for people with dementia just before and after nursing home placement: primary data from eight European countries
by Ansgar Wübker & Sandra Zwakhalen & David Challis & Riitta Suhonen & Staffan Karlsson & Adelaida Zabalegui & Maria Soto & Kai Saks & Dirk Sauerland - 709-717 Cost of care for cystic fibrosis: an investigation of cost determinants using national registry data
by Yuanyuan Gu & Sonia García-Pérez & John Massie & Kees Gool - 719-731 Recommendation of rotavirus vaccination and herd effect: a budget impact analysis based on German health insurance data
by Alexander Karmann & Andrea Jurack & Daniel Lukas - 733-745 Healthy donor effect and satisfaction with health
by Edlira Shehu & Annette Hofmann & Michel Clement & Ann-Christin Langmaack - 747-761 Using price–volume agreements to manage pharmaceutical leakage and off-label promotion
by Hui Zhang & Gregory Zaric - 763-780 Hospital staffing and local pay: an investigation into the impact of local variations in the competitiveness of nurses’ pay on the staffing of hospitals in France
by Jean-Baptiste Combes & Eric Delattre & Bob Elliott & Diane Skåtun - 781-796 Health system characteristics and unmet care needs in Europe: an analysis based on EU-SILC data
by Sabine Chaupain-Guillot & Olivier Guillot
July 2015, Volume 16, Issue 6
- 569-571 When do performance-based risk-sharing arrangements make sense?
by Michael Drummond - 573-587 A model-based cost-effectiveness analysis of a grommets-led care pathway for children with cleft palate affected by otitis media with effusion
by Syed Mohiuddin & Katherine Payne & Elisabeth Fenwick & Kevin O’Brien & Iain Bruce - 589-601 Productivity or discrimination? An economic analysis of excess-weight penalty in the Swedish labor market
by Margareta Dackehag & Ulf-G. Gerdtham & Martin Nordin - 603-612 Long-term effects of oral clefts on health care utilization: a sibling comparison
by Morten Pedersen & George Wehby & Dorthe Pedersen & Kaare Christensen - 613-628 Chronic pain patients’ treatment preferences: a discrete-choice experiment
by Axel Mühlbacher & Uwe Junker & Christin Juhnke & Edgar Stemmler & Thomas Kohlmann & Friedhelm Leverkus & Matthias Nübling - 629-645 The effect of neighbourhood mortality shocks on fertility preferences: a spatial econometric approach
by Nkechi Owoo & Samuel Agyei-Mensah & Emily Onuoha - 647-655 Cost-effectiveness of computed tomography coronary angiography versus conventional invasive coronary angiography
by Meryl Darlington & Pascal Gueret & Jean-Pierre Laissy & Antoine Pierucci & Hassani Maoulida & Céline Quelen & Ralph Niarra & Gilles Chatellier & Isabelle Durand-Zaleski - 657-670 Patients’ preferences: a discrete-choice experiment for treatment of non-small-cell lung cancer
by Axel Mühlbacher & Susanne Bethge - 671-681 Cost-effectiveness of nurse-based case management versus usual care for elderly patients with myocardial infarction: results from the KORINNA study
by Hildegard Seidl & Matthias Hunger & Reiner Leidl & Christa Meisinger & Rupert Wende & Bernhard Kuch & Rolf Holle
June 2015, Volume 16, Issue 5
- 455-457 Is personalized medicine a panacea for health management? Some thoughts on its desirability
by Fernando Antoñanzas & Carmelo Juárez-Castelló & Roberto Rodríguez-Ibeas - 459-469 Analysis of the cost and efficiency relationship: experience in the Turkish pay for performance system
by Mehmet Gok & Erkut Altındağ - 471-488 Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
by Oliver Damm & Martin Eichner & Markus Rose & Markus Knuf & Peter Wutzler & Johannes Liese & Hagen Krüger & Wolfgang Greiner - 489-506 Income-related inequity in the use of GP services by children: a comparison of Ireland and Scotland
by Richard Layte & Anne Nolan - 507-515 Economic valuation and determinants of informal care to people with Alzheimer’s disease
by Luz Peña-Longobardo & Juan Oliva-Moreno - 517-527 Cost-effectiveness of a multifactorial fracture prevention program for elderly people admitted to nursing homes
by Dirk Müller & Lisa Borsi & Claudia Stracke & Stephanie Stock & Björn Stollenwerk - 529-542 Physician–patient relationship and medical accident victim compensation: some insights into the French regulatory system
by Lydie Ancelot & Cornel Oros - 543-559 Health inequalities in the European Union: an empirical analysis of the dynamics of regional differences
by Laia Maynou & Marc Saez & Jordi Bacaria & Guillem Lopez-Casasnovas - 561-567 Consultant duration of clinical practice as a cost determinant of an emergency medical admission
by Seán Cournane & Richard Conway & Donnacha Creagh & Declan Byrne & Bernard Silke
May 2015, Volume 16, Issue 4
- 341-345 Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness?
by Katelijne Vooren & Alessandro Curto & Livio Garattini - 347-356 Using the SF-6D to measure the impact of alcohol dependence on health-related quality of life
by Jacinto Nogueira & Eva Rodríguez-Míguez - 357-364 Cost of managing anemia in end-stage renal disease: the experience of five French dialysis centers
by Jacques Rottembourg & Patrick Tilleul & Gilbert Deray & Antoine Lafuma & Lorraine Zakin & Lamine Mahi & Jorge Wernli - 365-375 The impact of office-based care on hospitalizations for ambulatory care sensitive conditions
by Leonie Sundmacher & Thomas Kopetsch - 377-390 Cost-effectiveness of modern mTOR inhibitor based immunosuppression compared to the standard of care after renal transplantation in Germany
by Jan Jürgensen & Robert Ikenberg & Roger-Axel Greiner & Volker Hösel - 391-405 The Icelandic economic collapse, smoking, and the role of labor-market changes
by Thorhildur Ólafsdóttir & Birgir Hrafnkelsson & Tinna Ásgeirsdóttir - 407-419 Does prospective payment increase hospital (in)efficiency? Evidence from the Swiss hospital sector
by Philippe Widmer - 421-435 Gender differences in French GPs’ activity: the contribution of quantile regressions
by Magali Dumontet & Carine Franc - 437-450 Cost-effectiveness of integrated care in frail elderly using the ICECAP-O and EQ-5D: does choice of instrument matter?
by Peter Makai & Willemijn Looman & Eddy Adang & René Melis & Elly Stolk & Isabelle Fabbricotti - 451-452 Comment on: “Impact and cost-effectiveness of a universal strategy to promote physical activity in primary care”
by Afschin Gandjour - 453-453 Reply to comment on “Impact and cost-effectiveness of a universal strategy to promote physical activity in primary care”
by Martin Gulliford & Judith Charlton & Nawaraj Bhattarai & Caroline Rudisill
April 2015, Volume 16, Issue 3
- 229-234 Reform of hospital financing in Austria: successes, failures, and the way forward
by Engelbert Theurl - 235-241 SF-6D Portuguese population norms
by Pedro Ferreira & Lara Ferreira & Luis Pereira - 243-254 Examining variations in hospital productivity in the English NHS
by Adriana Castelli & Andrew Street & Rossella Verzulli & Padraic Ward - 255-270 Financial catastrophe and poverty impacts of out-of-pocket health payments in Turkey
by Hacer Özgen Narcı & İsmet Şahin & Hasan Yıldırım - 271-277 On the calculation of the Israeli risk adjustment rates
by Amir Shmueli - 279-288 A duration analysis of the role of cigarette prices on smoking initiation and cessation in developing countries
by Deliana Kostova & Frank Chaloupka & Ce Shang - 289-303 Did the corporatization of Portuguese hospitals significantly change their productivity?
by Diogo Ferreira & Rui Marques - 305-311 Prevalence and treatment costs of type 2 diabetes in Germany and the effects of social and demographical differences
by D. Sittig & H. Friedel & J. Wasem - 313-328 Transforming EQ-5D utilities for use in cost–value analysis of health programs
by Erik Nord & Rune Johansen - 329-340 Equal health, equal work? The role of disability benefits in employment after controlling for health status
by Eva Frutos & Judit Castello
March 2015, Volume 16, Issue 2
- 113-118 Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems
by J.-Matthias Schulenburg & Martin Frank - 119-131 Costs and benefits of home care for the elderly versus residential care: a comparison using propensity scores
by Lucy Kok & Caroline Berden & Klarita Sadiraj - 133-139 Output correlations in probabilistic models with multiple alternatives
by Klemen Naveršnik - 141-151 Examining the impact of 11 long-standing health conditions on health-related quality of life using the EQ-5D in a general population sample
by Mengjun Wu & John Brazier & Benjamin Kearns & Clare Relton & Christine Smith & Cindy Cooper - 153-159 Accounting for trends in health poverty: a decomposition analysis for Britain, 1991–2008
by Michal Brzezinski - 161-173 The influence of obesity and overweight on medical costs: a panel data perspective
by Toni Mora & Joan Gil & Antoni Sicras-Mainar - 175-184 The influence of the economic crisis on the association between unemployment and health: an empirical analysis for Spain
by Rosa Urbanos-Garrido & Beatriz Lopez-Valcarcel - 185-199 Price elasticities of alcohol demand: evidence from Russia
by Yevgeniy Goryakin & Bayard Roberts & Martin McKee - 201-218 Improving the prediction model used in risk equalization: cost and diagnostic information from multiple prior years
by S. Veen & R. Kleef & W. Ven & R. Vliet - 219-223 Impact of small study bias on cost-effectiveness acceptability curves and value of information analyses
by Dirk Müller & Eleanor Pullenayegum & Afschin Gandjour - 225-226 Commentary to: costs of diabetes and its complications in Poland
by Ahmad Fayaz-Bakhsh & Raana Sarvari Mehrabad - 227-227 Reply to commentary on costs of diabetes and its complications in Poland
by Joanna Leśniowska
January 2015, Volume 16, Issue 1
- 1-3 Italian risk-sharing agreements on drugs: are they worthwhile?
by Livio Garattini & Alessandro Curto & Katelijne Vooren - 5-20 Misreporting and misclassification: implications for socioeconomic disparities in body-mass index and obesity
by Åsa Ljungvall & Ulf Gerdtham & Ulf Lindblad - 21-33 Income-related inequalities and inequities in health care services utilisation in 18 selected OECD countries
by Marion Devaux - 35-45 Demand uncertainty and hospital costs: an application to Portuguese public hospitals
by Alvaro Almeida & Joana Cima - 47-54 Do people desire to be healthier than other people? A short note on positional concerns for health
by S. Wouters & N. Exel & M. Donk & K. Rohde & W. Brouwer - 55-64 The impact of user fee removal policies on household out-of-pocket spending: evidence against the inverse equity hypothesis from a population based study in Burkina Faso
by V. Ridde & I. Agier & A. Jahn & O. Mueller & J. Tiendrebéogo & M. Yé & M. De Allegri - 65-72 Cost of poor adherence to anti-hypertensive therapy in five European countries
by F. Mennini & A. Marcellusi & J. Schulenburg & A. Gray & P. Levy & P. Sciattella & M. Soro & G. Staffiero & J. Zeidler & A. Maggioni & R. Schmieder - 73-82 Competitive pricing within pharmaceutical classes: evidence on “follow-on” drugs in Germany 1993–2008
by Michael Mueller & Alexander Frenzel - 83-94 Compulsory licensing and access to drugs
by Charitini Stavropoulou & Tommaso Valletti - 95-112 Health care expenditures and longevity: is there a Eubie Blake effect?
by Friedrich Breyer & Normann Lorenz & Thomas Niebel
December 2014, Volume 15, Issue 9
- 899-906 Analysing coverage decision-making: opening Pandora’s box?
by Katharina Fischer & Reiner Leidl - 907-916 Budget impact of parenteral iron treatment of iron deficiency: methodological issues raised by using real-life data
by Elisabeth Brock & Peter Braunhofer & Josef Troxler & Heinz Schneider - 917-925 Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain
by Álvaro Hidalgo-Vega & Juan Ramos-Goñi & Renata Villoro - 927-936 Patient hospital choice for hip replacement: empirical evidence from the Netherlands
by Puck Beukers & Ron Kemp & Marco Varkevisser - 937-951 Diffusion of pharmaceuticals: cross-country evidence of anti-TNF drugs
by Kurt Brekke & Dag Dalen & Tor Holmås - 953-966 Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I)
by Uwe Zettl & Thomas Henze & Ute Essner & Peter Flachenecker - 967-977 Validity and responsiveness of the EQ-5D and the KIDSCREEN-10 in children with ADHD
by Clazien Bouwmans & Annemarie Kolk & Mark Oppe & Saskia Schawo & Elly Stolk & Michel Agthoven & Jan Buitelaar & LeonaHakkaart Roijen - 979-989 The impact of ageing on health care expenditures: a study of steepening
by Fredrik Gregersen - 991-998 Brand switching or reduced consumption? A study of how cigarette taxes affect tobacco consumption
by Chiang-Ming Chen & Kuo-Liang Chang & Lin Lin & Jwo-Leun Lee - 999-1010 Cost effects of hospital mergers in Portugal
by Helda Azevedo & Céu Mateus
November 2014, Volume 15, Issue 8
- 787-790 Considering productivity loss in cost-effectiveness analysis: a new approach
by Afschin Gandjour - 791-800 The impact of memantine in combination with acetylcholinesterase inhibitors on admission of patients with Alzheimer’s disease to nursing homes: cost-effectiveness analysis in France
by Jacques Touchon & Jean Lachaine & Catherine Beauchemin & Anna Granghaud & Benoit Rive & Sébastien Bineau